It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ergogenic aides are widely used by fitness enthusiast and athletes to increase performance. Alpha Glycerylphosphorylcholine (A-GPC) has demonstrated some initial promise in changing explosive performance. The purpose of the present investigation was to determine if 6 days of supplementation with A-GPC would augment isometric force production compared to a placebo. Thirteen college aged males (Means ± SD; Age: 21.9 ± 2.2 yrs, Height: 180.3 ± 7.7 cm, Weight: 87.6 ± 15.6 kg; VO2 max: 40.08 ± 7.23 ml O2*Kg-1*min-1, Body Fat: 17.5 ± 4.6 %) gave written informed consent to participate in the study. The study was a double blind placebo controlled, cross-over design. The participants reported to the lab for an initial visit where they were familiarized with the isometric mid-thigh pull in a custom squat cage on a force platform and upper body isometric test against a high frequency load cell, and baseline measurements were taken for both. The participant then consumed either 600 mg per day of A-GPC or placebo, and at the end of 6 days, performed isometric mid-thigh pull and an upper body isometric test. A one week washout period was used before the participants baseline was re-measured and crossed over to the other treatment. The A-GPC treatment resulted in significantly greater isometric mid-thigh pull peak force change from baseline (t= 1.76, p=0.044) compared with placebo (A-GPC: 98.8.±236.9N vs Placebo: -39.0±170.9N). For the upper body test, the A- GPC treatment trended towards greater change from baseline force production (A-GPC: 50.9±167.2N Placebo: -14.9±114.9N), but failed to obtain statistical significance (t=1.16, p=0.127). The study found that A-GPC is effective at increasing lower body force production after 6 days of supplementation. Sport performance coaches can consider adding A-GPC to the diet of speed and power athletes to enhance muscle performance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer